Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
FDMT —
4D MOLECULAR THERAPEUTICS IN
CUSIP: 35104E100 · Held by 2 superinvestors · Combined value: $4,378,418
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $3,846,750 | 512,900 | ADD | +199,714 |
| 2 | Ken Griffin | 0.0% | $531,668 | 70,889 | ADD | +35,089 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +199,714 | +63.8% |
| Ken Griffin | ADD | +35,089 | +98.0% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +196,633 | +168.7% |
| Ken Griffin | REDUCE | -210,239 | -85.4% |
Who Owns FDMT? Superinvestor Holdings
4D MOLECULAR THERAPEUTICS IN is held by 2 tracked superinvestors, with a combined position value of $4 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.